Sort
261,768 grants matching “gene therapy”
Development Of New Approaches To Vaccines Against TBEV and West Nile Virus
$997,471Alexander Pletnev · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Center for Cellular Metabolism Research in Oklahoma
$997,408Lijun Xia · Oklahoma Medical Research Foundation · P20 · FY2024 · GM
Mechanisms of Therapy and Model Development in Viral Hepatitis and Liver Diseases
$997,377T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
ER mitochondrial signaling and alcoholic tissue injury
$997,350Gyorgy Hajnoczky · Thomas Jefferson University · RC2 · FY2009 · AA
RP3: Therapeutics Human Monoclonal Antibody Treatments for Filoviruses
$997,348James E Crowe · University Of Texas Med Br Galveston · U19 · FY2018 · AI
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
$997,290Thomas M Roberts · Dana-Farber Cancer Inst · R35 · FY2024 · CA
Genomic and Epigenomic Mechanisms of Maternal E-Cigarette induced Abnormal Brain Development
$997,279Charles Wang · Loma Linda University · U01 · FY2023 · DA
Bright, Photostable Surface Enhanced Fluorescent Nanotags
$997,267Aaron Saunders · Nanocomposix, Inc. · N01 · FY2013 · CA
Evaluation Of A Novel Connexin-Based Peptide For The Treatment Of Diabetic Wounds
$997,264Gautam Sudhir Ghatnekar · Xequel Bio, Inc. · R44 · FY2016 · DK
Identifying T2D Variants by DNA Sequencing in Multiethnic Samples
$997,224Michael Boehnke · University Of Michigan At Ann Arbor · U01 · FY2010 · DK
Hematopoiesis from Normal and Patient-Derived Induced Pluripotent Stem Cells
$997,217Mitchell J Weiss · Children'S Hosp Of Philadelphia · RC2 · FY2009 · HL
Targeting lipid rafts for treatment of asthma
$997,203Yakov Kogan · Raft Pharmaceuticals, Llc · R44 · FY2024 · AI
Excitotoxicity in Circulatory Arrest ? Brain Injury
$997,200William Anthony Baumgartner · Johns Hopkins University · R01 · FY2009 · HL
Discovery of Risk Loci and Genomics of Pancreatic Cancer through Exome Sequencing
$997,116Paul A Scheet · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's disease (AD)
$996,923Paul B Rosenberg · Johns Hopkins University · R01 · FY2017 · AG
Cellular Strategies for Tolerance Induction
$996,881Andrew B Adams · Emory University · U19 · FY2020 · AI
Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation
$996,868Sanford D Markowitz · Case Western Reserve University · U01 · FY2024 · CA
Identification of Master Regulators for stem cell pluripotency and self-renewal
$996,817Michael M. Shen · Columbia University Health Sciences · RC1 · FY2010 · GM
Optimization and Validation of an Indicator Cell Assay for Blood-Based Diagnosis of Alzheimer's Disease
$996,801Jennifer Joy Smith · Precyte, Inc. · R44 · FY2018 · AG
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
$996,733Norman E Breslow · Fred Hutchinson Cancer Research Center · R01 · FY2008 · CA
Multiplexed Assay for Point-of-Care UTI Diagnosis (ID/AMR)
$996,726Alison Burklund · Nanopathdx, Inc. · R44 · FY2024 · AI
How do genome alterations cause human lung cancer?
$996,674Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2019 · CA
Differential function and tumor vulnerabilities revealed by RAS membrane trafficking
$996,661Mark Reid Philips · New York University School Of Medicine · R35 · FY2022 · CA
Biology and genetics of metastatic disease
$996,660Sohail F. Tavazoie · Rockefeller University · R35 · FY2023 · CA
Mechanisms of Platelet Activity in Vascular Disease
$996,660Jeffrey S Berger · New York University School Of Medicine · R35 · FY2024 · HL